Rare diseases
Investigational molecules
Locations
Back to Portugal680 clinical trials in Vila Nova De Gaia, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)Study on the Safety and Effectiveness of Crinecerfont for Adults with Classic Congenital Adrenal Hyperplasia
PortugalStudy on the Effectiveness of Inavolisib, Atezolizumab, and Entrectinib in Patients with Advanced or Metastatic Solid Tumors
PortugalStudy on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin
PortugalStudy on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma
PortugalStudy on the Effectiveness and Safety of Iptacopan with Drug Combination for Adults with Active Lupus Nephritis Class III-IV, +/- V
PortugalStudy Comparing Somapacitan and Somatropin for Growth in Children with Short Stature Due to Small for Gestational Age, Turner Syndrome, Noonan Syndrome, or Idiopathic Short Stature
PortugalStudy on Trastuzumab and Pertuzumab for Patients with HER2-Positive Breast Cancer Using a Response-Adapted Strategy
PortugalStudy on Dose Flexibility of Upadacitinib for Adults with Moderate to Severe Atopic Dermatitis
PortugalStudy on Asundexian and Apixaban for Preventing Stroke in Adults with Atrial Fibrillation at Risk for Stroke
PortugalStudy of MK-7684A with Chemoradiotherapy Compared to Chemoradiotherapy with Durvalumab for Patients with Stage III Non-Small Cell Lung Cancer
PortugalStudy on Zetomipzomib for Patients with Active Lupus Nephritis
PortugalStudy of mRNA-4157 and Pembrolizumab for Patients with High-Risk Stage II-IV Melanoma
PortugalThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on head and neck cancer, breast cancer, and multiple myeloma treatments. Studies include evaluations of novel therapies for both early-stage and metastatic conditions.
Research encompasses targeted therapies and combination treatments aimed at improving patient outcomes.
Comprehensive studies investigating treatments for various autoimmune conditions, including Sjögren's Syndrome and systemic sclerosis. Focus on developing targeted therapies for immune system regulation.
Evaluating novel biological therapies to address complex autoimmune manifestations.
Research focused on obesity management and cardiovascular health. Studies evaluate new therapeutic approaches for weight management and cardiovascular disease prevention.
Investigating innovative treatments to address growing metabolic health challenges.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
